journal article·2018-05-19Open access

Recent advances on biomedical applications of scaffolds in wound healing and dermal tissue engineering

Azizeh Rahmani Del Bakhshayesh, Nasim Annabi, Rovshan Khalilov, Abolfazl Akbarzadeh, Mohammad Samiei, Effat Alizadeh, Mohammadreza Alizadeh-Ghodsi, Soodabeh Davaran, Azadeh Montaseri

Abstract

The tissue engineering field has developed in response to the shortcomings related to the replacement of the tissues lost to disease or trauma: donor tissue rejection, chronic inflammation and donor tissue shortages. The driving force behind the tissue engineering is to avoid the mentioned issues by creating the biological substitutes capable of replacing the damaged tissue. This is done by combining the scaffolds, cells and signals in order to create the living, physiological, three-dimensional tissues. A wide variety of skin substitutes are used in the treatment of full-thickness injuries. Substitutes made from skin can harbour the latent viruses, and artificial skin grafts can heal with the extensive scarring, failing to regenerate structures such as glands, nerves and hair follicles. New and practical skin scaffold materials remain to be developed. The current article describes the important information about wound healing scaffolds. The scaffold types which were used in these fields were classified according to the accepted guideline of the biological medicine. Moreover, the present article gave the brief overview on the fundamentals of the tissue engineering, biodegradable polymer properties and their application in skin wound healing. Also, the present review discusses the type of the tissue engineered skin substitutes and modern wound dressings which promote the wound healing.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Electrospun Nanofibers in Biomedical Applications · Wound Healing and Treatments · Silk-based biomaterials and applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Medical Nanotechnology, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences

Student Research Committee, Tabriz University of Medical Sciences

Biomaterials Innovation Research Center, Brigham and Women's Hospital, Harvard Medical School

Harvard-MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology

Department of Chemical Engineering, Northeastern University

Institute of Radiation Problems, National Academy of Sciences of Azerbaijan

Stem Cell Research Center, Tabriz University of Medical Sciences

Department of Endodontics, Faculty of Dentistry, Tabriz University of Medical Sciences

Drug Applied Research Center, Tabriz University of Medical Sciences

Department of Anatomical Sciences, Tabriz University of Medical Sciences

Funding

Tabriz University of Medical Sciences

References (100+)

Show source-provided references
1. 10.1155/2009/48671010.1155/2009/486710 ↗
2. 10.1016/j.biomaterials.2003.09.01110.1016/j.biomaterials.2003.09.011 ↗
3. 10.2106/JBJS.G.0126010.2106/JBJS.G.01260 ↗
4. 10.1155/2011/29060210.1155/2011/290602 ↗
5. 10.1016/S0169-409X(98)00021-010.1016/S0169-409X(98)00021-0 ↗
6. 10.1016/j.progpolymsci.2007.05.01710.1016/j.progpolymsci.2007.05.017 ↗
7. Sravanthi R. Preparation and characterization of poly (ɛ-caprolactone) PCL scaffolds for tissue engineering applications [Thesis]. Rourkela (India): National Institute of Technology; 2009.
8. 10.1586/17434440.3.6.83510.1586/17434440.3.6.835 ↗
9. 10.3109/21691401.2015.103699910.3109/21691401.2015.1036999 ↗
10. 10.3109/21691401.2015.111123210.3109/21691401.2015.1111232 ↗
11. 10.1002/0471732877.emd02910.1002/0471732877.emd029 ↗
12. 10.1007/978-1-4612-4154-6_110.1007/978-1-4612-4154-6_1 ↗
13. 10.1089/ten.1996.2.25510.1089/ten.1996.2.255 ↗
14. 10.1002/(SICI)1097-4636(19991215)47:4<494::AID-JBM5>3.0.CO;2-L10.1002/(SICI)1097-4636(19991215)47:4<494::AID-JBM5>3.0.CO;2-L ↗
15. 10.1007/BF0026210610.1007/BF00262106 ↗
16. 10.1089/10763270032074810.1089/107632700320748 ↗
17. 10.1097/00004630-199309000-0000110.1097/00004630-199309000-00001 ↗
18. 10.1016/S0142-9612(98)00021-010.1016/S0142-9612(98)00021-0 ↗
19. 10.1097/00006534-199708000-0000110.1097/00006534-199708000-00001 ↗
20. 10.1089/ten.1999.5.44310.1089/ten.1999.5.443 ↗
21. 10.1002/jbm.a.2000910.1002/jbm.a.20009 ↗
22. 10.1007/s00223-004-0150-910.1007/s00223-004-0150-9 ↗
23. 10.1097/00001665-199601000-0001010.1097/00001665-199601000-00010 ↗
24. 10.1016/8756-3282(95)00085-R10.1016/8756-3282(95)00085-R ↗
25. 10.1615/JLongTermEffMedImplants.v16.i1.7010.1615/JLongTermEffMedImplants.v16.i1.70 ↗
26. 10.1073/pnas.15232409910.1073/pnas.152324099 ↗
27. 10.1177/03913988060290080610.1177/039139880602900806 ↗
28. 10.1126/science.150.3698.89310.1126/science.150.3698.893 ↗
29. 10.1097/00006254-198905000-0002810.1097/00006254-198905000-00028 ↗
30. 10.1016/j.addr.2007.03.01410.1016/j.addr.2007.03.014 ↗
31. 10.1016/j.actbio.2008.02.00710.1016/j.actbio.2008.02.007 ↗
32. 10.1016/j.biomaterials.2005.07.02710.1016/j.biomaterials.2005.07.027 ↗
33. 10.1007/s10544-007-9155-210.1007/s10544-007-9155-2 ↗
34. 10.1089/ten.2004.10.151010.1089/ten.2004.10.1510 ↗
35. 10.1097/00000658-198110000-0000510.1097/00000658-198110000-00005 ↗
36. 10.1054/bjps.2000.352510.1054/bjps.2000.3525 ↗
37. 10.1097/00004630-200301000-0000910.1097/00004630-200301000-00009 ↗
38. 10.1016/j.ejvs.2006.08.00810.1016/j.ejvs.2006.08.008 ↗
39. 10.1021/bm050431f10.1021/bm050431f ↗
40. 10.1002/(SICI)1096-9861(19960212)365:3<380::AID-CNE4>3.0.CO;2-010.1002/(SICI)1096-9861(19960212)365:3<380::AID-CNE4>3.0.CO;2-0 ↗
41. 10.1096/fasebj.13.15.221410.1096/fasebj.13.15.2214 ↗
42. 10.1089/ten.teb.2007.043510.1089/ten.teb.2007.0435 ↗
43. 10.1002/jps.2121010.1002/jps.21210 ↗
44. 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-710.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7 ↗
45. 10.1016/j.addr.2007.03.01210.1016/j.addr.2007.03.012 ↗
46. 10.1016/j.biomaterials.2005.03.03010.1016/j.biomaterials.2005.03.030 ↗
47. 10.1016/j.biomaterials.2007.06.02510.1016/j.biomaterials.2007.06.025 ↗
48. 10.1088/1748-6041/1/2/00410.1088/1748-6041/1/2/004 ↗
49. 10.1016/j.actbio.2012.06.03210.1016/j.actbio.2012.06.032 ↗
50. 10.1021/cr030441b10.1021/cr030441b ↗
51. 10.1007/PL0000058410.1007/PL00000584 ↗
52. 10.1016/S0144-8617(03)00076-610.1016/S0144-8617(03)00076-6 ↗
53. 10.1016/S0142-9612(02)00566-510.1016/S0142-9612(02)00566-5 ↗
54. 10.1016/S0169-409X(01)00189-210.1016/S0169-409X(01)00189-2 ↗
55. 10.1016/j.burns.2005.10.01510.1016/j.burns.2005.10.015 ↗
56. 10.1016/j.ijbiomac.2012.08.00410.1016/j.ijbiomac.2012.08.004 ↗
57. 10.1002/jbm.a.3284810.1002/jbm.a.32848 ↗
58. 10.1089/ten.tea.2008.025110.1089/ten.tea.2008.0251 ↗
59. 10.1111/j.1469-7580.2009.01066.x10.1111/j.1469-7580.2009.01066.x ↗
60. 10.1016/S0168-1656(01)00395-910.1016/S0168-1656(01)00395-9 ↗
61. 10.1016/S1567-5394(02)00032-410.1016/S1567-5394(02)00032-4 ↗
62. Bhardwaj N, Sow WT, Devi D, et al. Silk fibroin–keratin based 3D scaffolds as a dermal substitute for skin tissue engineering. Integr Biol. 2015;7:53–63.10.1039/C4IB00208C ↗
63. Christensen B. Alginates as biomaterials in tissue engineering. In: Rauter AP, Lindhorst TK, editors. Carbohydrate chemistry: chemical and biological approaches. Vol. 37. Cambridge (UK): RSC Publishing; 2011. p. 227–258.
64. 10.1002/pat.90610.1002/pat.906 ↗
65. Wounds U. Best practice statement: the use of topical antiseptic/antimicrobial agents in wound management. London (UK): Wounds; 2010.
66. 10.1016/j.ijpharm.2012.08.00110.1016/j.ijpharm.2012.08.001 ↗
67. 10.1111/j.1742-481X.2012.00927.x10.1111/j.1742-481X.2012.00927.x ↗
68. Barnett S, Varley S. The effects of calcium alginate on wound healing. Ann R Coll Surg Engl. 1987;69:153.
69. 10.1016/j.biomaterials.2005.04.01210.1016/j.biomaterials.2005.04.012 ↗
70. 10.3390/ma604128510.3390/ma6041285 ↗
71. 10.3390/md1305289010.3390/md13052890 ↗
72. 10.1002/mabi.20120040910.1002/mabi.201200409 ↗
73. 10.1166/jbt.2014.118710.1166/jbt.2014.1187 ↗
74. 10.1166/jbt.2012.103710.1166/jbt.2012.1037 ↗
75. 10.3109/10731199.2010.49458010.3109/10731199.2010.494580 ↗
76. 10.1016/j.ijbiomac.2015.08.03810.1016/j.ijbiomac.2015.08.038 ↗
77. 10.1166/jbt.2015.133810.1166/jbt.2015.1338 ↗
78. 10.3109/21691401.2014.98667610.3109/21691401.2014.986676 ↗
79. 10.1046/j.1524-475X.1999.00079.x10.1046/j.1524-475X.1999.00079.x ↗
80. 10.1097/BCR.0B013E318031A23610.1097/BCR.0B013E318031A236 ↗
81. 10.1111/j.1440-1681.2011.05627.x10.1111/j.1440-1681.2011.05627.x ↗
82. 10.1016/S1387-2656(06)12009-810.1016/S1387-2656(06)12009-8 ↗
83. 10.1089/10763270376268754610.1089/107632703762687546 ↗
84. 10.1089/ten.1996.2.19710.1089/ten.1996.2.197 ↗
85. Khalilov RI, Khomutov GB, Tikhonov AN. Effect of ultraviolet radiation on structural-functional characteristics of the thylakoid membrane. Russ Plant Physiol. 1993;3:338–342.
86. 10.1016/j.polymer.2005.02.12010.1016/j.polymer.2005.02.120 ↗
87. 10.1007/978-981-10-0875-7_2110.1007/978-981-10-0875-7_21 ↗
88. 10.1002/1616-5195(20020201)2:2<67::AID-MABI67>3.0.CO;2-F10.1002/1616-5195(20020201)2:2<67::AID-MABI67>3.0.CO;2-F ↗
89. 10.1108/1355254091092504510.1108/13552540910925045 ↗
90. Williams D, Mort E. Enzyme-accelerated hydrolysis of polyglycolic acid. J Bioeng. 1977;1:231–238.
91. 10.1002/jbm.a.3480110.1002/jbm.a.34801 ↗
92. 10.1089/10763270175333771710.1089/107632701753337717 ↗
93. 10.3109/10731199.2012.67533710.3109/10731199.2012.675337 ↗
94. Amirthalingam M, Kasinathan N, Amuthan A, et al. Bioactive PLGA–curcumin microparticle-embedded chitosan scaffold: in vitro and in vivo evaluation. Artif Cells Blood Subst Biotechnol. 2017;45:233–241.
95. 10.1002/jbm.121710.1002/jbm.1217 ↗
96. 10.1016/j.biomaterials.2007.03.00410.1016/j.biomaterials.2007.03.004 ↗
97. 10.1016/S0142-9612(01)00051-510.1016/S0142-9612(01)00051-5 ↗
98. 10.1016/S1359-6446(05)03575-010.1016/S1359-6446(05)03575-0 ↗
99. Vahidi M, Frounchi M, Dadbin S. Porous gelatin/poly (ethylene glycol) scaffolds for skin cells. Soft Mater. 2016;15:95–102.
100. 10.1002/anie.19930477110.1002/anie.199304771 ↗